UroGen Pharma Ltd. — Director's Dealing 2021

Jun 9, 2021

SEC Form 4/A — Form 4/A

Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2021-03-26

Reporting Person: Belldegrun Arie (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-26	Ordinary Shares	M	3241	$5.00	Acquired	245452	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-26	Stock Option (right to buy)	$5.00	M	3241	Disposed	2021-07-27	Ordinary Shares (3241)	Direct

Footnotes

F1: On April 22, 2021, the reporting person filed a Form 4 that mistakenly listed the transaction date as March 24, 2021.